These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 4917326)
21. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate). Braunsteiner H; Herbst M; Sandhofer F; Sailer S Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144 [No Abstract] [Full Text] [Related]
22. Trial of "Atheran" and "Atromid-S" in atherosclerosis. Barnett AJ; Carson V Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995 [No Abstract] [Full Text] [Related]
23. Divergent effects in the treatment of hyperlipemia. Slowe IA; Carter AC; Feldman EB Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355 [No Abstract] [Full Text] [Related]
24. [Action mechanism and clinical success of Regelan (Clofibrate)]. Fitzgerald JD Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437 [No Abstract] [Full Text] [Related]
25. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis]. Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081 [No Abstract] [Full Text] [Related]
26. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts. Engström J Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263 [No Abstract] [Full Text] [Related]
27. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate]. Barisone D; Gallo G; Accardo S Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766 [No Abstract] [Full Text] [Related]
28. Management of coronary artery disease. Br Med J; 1969 Jan; 1(5635):37-8. PubMed ID: 4973519 [No Abstract] [Full Text] [Related]
29. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease]. Fischer M; Irsigler K Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993 [No Abstract] [Full Text] [Related]
31. Atromid-S for the reduction of plasma lipids. Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633 [No Abstract] [Full Text] [Related]
32. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia]. Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028 [No Abstract] [Full Text] [Related]
33. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM; Duncan CH Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
34. Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia. Scott PJ; Hurley PJ J Atheroscler Res; 1969; 9(1):25-34. PubMed ID: 5779579 [No Abstract] [Full Text] [Related]